🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Gastric cancer is one of the cancers with a high mortality rate globally, a...
Status
Recruiting
Location
Changzhi People's Hospital
Start Date
2025-01-01
Trial ID
NCT07069842
Head and neck squamous cell carcinoma is one of the most common malignant t...
Status
Not Yet Recruiting
Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Start Date
2025-03-20
Trial ID
NCT06815705
Treatments Being Tested
RATIONALE: Studying samples of blood and tissue from smokers (closed to ent...
Status
Completed
Location
Providence Cancer Center
Start Date
2005-10
Trial ID
NCT00450281
Treatments Being Tested
The invesigators seek to devise a strategy for the assessment of Rivaroxaba...
Status
Completed
Location
University of Pittsburgh Medical Center, PUH, 200 Lothrop Street
Start Date
2016-04
Trial ID
NCT02651909
Treatments Being Tested
The goal of this multicenter observational study is to evaluate the lung ca...
Status
Unknown
Location
Zongda Hospital affiliated to Southeast University
Start Date
2023-01-29
Trial ID
NCT05707585
Treatments Being Tested
Angioedema is a common condition, with multiple etiologies. Type 3 angioed...
Status
Completed
Location
CHU Brugmann
Start Date
2018-10-29
Trial ID
NCT03917680
Treatments Being Tested
The anticoagulants have been developed with new generation for FDA-approved...
Status
Unknown
Location
Kaohsiung Medical University Hospital
Start Date
2019-01-02
Trial ID
NCT04056143
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as panitumumab, can block tumor grow...
Status
Completed
Location
Centre Paul Papin
Start Date
2008-06
Trial ID
NCT00655499
In the context of hemophilia, it is well know that the level of factor VIII...
Status
Unknown
Location
CHU Brugmann
Start Date
2017-01
Trial ID
NCT02803502
Treatments Being Tested